Patent · US Active

Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments

US7750000B2 · kind B2 · utility

13Cited by

1References

2Claims

0Family size

Assignee

Bayer Schering Pharma AG · DE

Inventors

Olaf Prien · Berlin, DE
Stuart Ince · Berlin, DE
Knut Eis · Berlin, DE
Christoph Huwe · Berlin, DE
Ulrich Lücking · Berlin, DE
Rolf Jautelat · Haan, DE
Ulrich Zügel · Berlin, DE
Judith Günther · Berlin, DE
Benjamin Bader · Berlin, DE
Manfred Husemann · Hohen Neuendorf, DE
Karina Schuck · Berlin, DE

Key dates

Filing date	Sep 1, 2006
Grant date	Jul 6, 2010
Priority date	—
Expiry date	Feb 10, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to novel inhibitors of kinases, and pharmaceutical compositions comprising them. The inhibitors are substituted imidazo[1,2b]pyridazines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.